Stanford Study Reveals Hidden Influenza Severity Risk Factor: What You Need to Know
- Some flu strains are more harmful than others, as seen during past pandemics.
- Wang's research team discovered that sugar molecules on antibodies significantly impact flu severity.
- Antibodies, vital for our immune defense, can be modified to enhance their anti-inflammatory response.
Sialic acid levels on antibodies reduce flu severity by controlling inflammation, not viral replication. This discovery could help manage severe infections and other inflammatory diseases.
Antibody Structure and Flu Severity
Influenza viruses evolve rapidly. This evolution is why annual flu shots are necessary. Some flu strains are more harmful than others, as seen during past pandemics. Taia Wang, an expert in infectious diseases, emphasizes that influenza remains a significant health threat.
Wang’s research team discovered that sugar molecules on antibodies significantly impact flu severity. They found that the abundance of sialic acid on antibodies can help protect against severe flu symptoms in mice, regardless of the virus strain.
Inflammation vs. Viral Replication
Antibodies, vital for our immune defense, can be modified to enhance their anti-inflammatory response. This response prevents severe lung damage during flu infections. Instead of solely fighting the virus, the focus shifts to controlling inflammation, which can be more damaging than the virus itself.
Sialic acid (blue links) at the end of sugar chains attached to antibodies (red) induce the antibodies to bind to receptors (light blue) promoting an anti-inflammatory response.
Antibodies are Y-shaped molecules that target pathogens. Their structure enables them to block viruses from entering cells. The importance of sialic acid lies in how it affects the antibody’s ability to manage inflammation.
The Role of Alveolar Macrophages
Wang’s team tested the impact of antibodies with different sialic acid levels on mice. They found that sialic acid-rich antibodies offered protection against severe flu by reducing lung inflammation. The antibodies triggered alveolar macrophages to adopt an anti-inflammatory state, enhancing lung function and oxygen exchange.
Simplicity of Antibody Function
The study questioned whether the entire antibody was necessary for protection or if the stalk alone could suffice. High-sialic acid antibody stalks could effectively reduce flu severity. Ongoing research will determine if these antibody stalks can predict flu disease progression in humans.
This research could extend beyond influenza, potentially impacting various infectious diseases and inflammatory conditions. The age of individuals may correlate with sialic acid levels in antibodies, linking to inflammation-related health issues prevalent in older populations.
The findings may lead to new approaches in managing both infections and inflammation, enhancing patient care across different medical conditions.
Reference: “Sialylated IgG induces the transcription factor REST in alveolar macrophages to protect against lung inflammation and severe influenza disease” by Saborni Chakraborty et al., published in Immunity on November 13, 2024. DOI: 10.1016/j.immuni.2024.10.002.